India Oncology NGS Market Size, Share & Trends Analysis Report By End-use (Clinical Research, Hospitals & Clinics), By Technology, By Application, By Product & Service, By Workflow, And Segment Forecasts, 2021 - 2028

Table of Contents

Chapter 1 Methodology And Scope
1.1 Research Assumptions
1.2 Research Methodology
1.3 Information Procurement
1.4 Information or Data Analysis
1.5 Market Formulation & Validation
1.6 Model
1.7 Market Model
1.8 Global Market: CAGR Calculation
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Landscape
2.4 Market Summary
Chapter 3 India Oncology Next Generation Sequencing Market: Industry Outlook
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping, by Technology, 2020
3.3 Next-Generation Sequencing Reimbursement Environment
3.3.1 Role Of The Commercial Payers
3.4 Regulatory and Political Environment
3.5 Market Dynamics
3.5.1 Market Driver Analysis
3.5.1.1 Exponentially decreasing costs for genetic sequencing
3.5.1.2 Development of companion diagnostics and personalized medicine
3.5.1.3 Technological advancements in cloud computing and data integration
3.5.1.4 Increasing prevalence of cancer
3.5.2 Market Restraint Analysis
3.5.2.1 Lack of computational efficiency for data management
3.5.2.2 Challenges associated with NGS implementation
3.5.3 Market Opportunity Analysis
3.5.3.1 Efforts taken to develop genomic databases for the Indian population
3.6 Business Environment Analysis
3.6.1 Swot分析;通过因素(政治和法律,Economic And Technological)
3.6.2 Porter’s Five Forces Analysis
3.7 Impact of COVID-19 Pandemic
3.7.1 Impact On The Supply Chain
3.7.2 Role Of Ngs To Combat Covid-19 Outbreak
3.7.3 Key Initiatives In India
Chapter 4 India Oncology Next Generation Sequencing Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Major Deals & Strategic Alliances Analysis
4.3.1 Mergers & Acquisitions
4.3.2 Licensing, Partnership Joint Ventures, & Collaborations
4.4 Market Entry Strategies
Chapter 5 Technology Business Analysis
5.1 India Oncology NGS Market: Technology Movement Analysis
5.2 Whole Genome Sequencing
5.2.1 India Oncology Whole Genome Sequencing Market Estimates And Forecast, 2017 - 2028 (USD Million)
5.2.2 Whole Exome Sequencing
5.2.2.1 India Oncology Whole Exome Sequencing Market Estimates And Forecast, 2017 - 2028 (USD Million)
5.2.3 Targeted & Gene Panel Sequencing
5.2.3.1 India Oncology Targeted & Gene Panel Sequencing Market Estimates And Forecast, 2017 - 2028 (USD Million)
5.2.4 Amplicon-Based
5.2.4.1 India oncology NGS Amplicon-based market estimates and forecast, 2017 - 2028 (USD Million)
5.2.5 Hybridization-Based
5.2.5.1 India oncology NGS Hybridization-based market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 6 Application Business Analysis
6.1 India Oncology NGS Market: Application Movement Analysis
6.2 Diagnostics and Screening
6.2.1 India Ngs-Based Oncology Diagnostics And Screening Market Estimates And Forecast, 2017 - 2028 (USD Million)
6.2.2 Screening
6.2.2.1 India NGS-based oncology screening market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2.2 Sporadic Cancer Screening
6.2.2.2.1 India NGS-based sporadic cancer screening market estimates and forecast, 2017 - 2028 (USD Million)
6.2.2.3 Inherited Cancer Screening
6.2.2.3.1 India NGS-based inherited cancer screening market estimates and forecast, 2017 - 2028 (USD Million)
6.2.3 Companion Diagnostics (CDX)
6.2.3.1 India NGS-based oncology CDx market estimates and forecast, 2017 - 2028 (USD Million)
6.2.4 Other Diagnostics
6.2.4.1 India NGS-based oncology CDx market estimates and forecast, 2017 - 2028 (USD Million)
6.3 Research Studies
6.3.1 India Ngs-Based Oncology Research Studies Market Estimates And Forecast, 2017 - 2028 (USD Million)
Chapter 7 Product & Service Business Analysis
7.1 India Oncology Next-Generation Sequencing Market: Product & Service Movement Analysis
7.2 NGS Platforms and Related Products
7.2.1 India Oncology Ngs Platforms And Related Products Market Estimates And Forecast, 2017 - 2028 (USD Million)
7.2.2 Panel
7.2.2.1 India oncology NGS panel market estimates and forecast, 2017 - 2028 (USD Million)
7.2.3 Consumables
7.2.3.1 India oncology NGS consumables market estimates and forecast, 2017 - 2028 (USD Million)
7.2.4 Platforms
7.2.4.1 India oncology NGS platforms market estimates and forecast, 2017 - 2028 (USD Million)
7.3 NGS Services
7.3.1 India Oncology Ngs Services Market Estimates And Forecast, 2017 - 2028 (USD Million)
Chapter 8 Workflow Business Analysis
8.1 India Oncology NGS Market: Workflow Movement Analysis
8.2 Pre-Sequencing
8.2.1 India Oncology Ngs Pre-Sequencing Market Estimates And Forecast, 2017 - 2028 (USD Million)
8.2.2 Ngs Library Preparation Kits
8.2.2.1 India oncology NGS Library Preparation kits market estimates and forecast, 2017 - 2028 (USD Million)
8.2.3 Semi-Automated Library Preparation
8.2.3.1 India oncology Semi-Automated Library Preparation market estimates and forecast, 2017 - 2028 (USD Million)
8.2.4 Automated Library Preparation
8.2.4.1 India oncology automated Library Preparation market estimates and forecast, 2017 - 2028 (USD Million)
8.2.5 Clonal Amplification
8.2.5.1 India oncology clonal amplification market estimates and forecast, 2017 - 2028 (USD Million)
8.3 Sequencing
8.3.1 India Oncology Ngs Sequencing Market Estimates And Forecast, 2017 - 2028 (USD Million)
8.4 NGS Data Analysis
8.4.1 India Oncology Ngs Data Analysis Market Estimates And Forecast, 2017 - 2028 (USD Million)
8.4.2门店主要数据分析
8.4.2.1 India oncology NGS primary data analysis market estimates and forecast, 2017 - 2028 (USD Million)
8.4.3 Ngs Secondary Data Analysis
8.4.3.1 India oncology NGS secondary data analysis market estimates and forecast, 2017 - 2028 (USD Million)
8.4.4 Ngs Tertiary Data Analysis
8.4.4.1 India oncology NGS tertiary data analysis market estimates and forecast, 2017 - 2028 (USD Million)
Chapter 9 End-Use Business Analysis
9.1 India Oncology Next Generation Sequencing Market: End-use Movement Analysis
9.2 Academic Research
9.2.1 Academic Research-Based India Oncology Ngs Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.3 Clinical Research
9.3.1 Clinical Research-Based India Oncology Ngs Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.4 Hospitals & Clinics
9.4.1 Hospitals & Clinics -Based India Oncology Ngs Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.5 Pharma & Biotech Entities
9.5.1 Pharma & Biotech Entities-Based India Oncology Ngs Market Estimates And Forecast, 2017 - 2028 (USD Million)
9.6 Other Users
9.6.1 Other Users-Based India Oncology Ngs Market Estimates And Forecast, 2017 - 2028 (USD Million)
Chapter 10 Competitive Landscape
10.1 Company Profiles
10.1.1 ILLUMINA, INC.
10.1.1.1 Company overview
10.1.1.2 Financial Performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 GENOTYPIC TECHNOLOGY PVT. LTD.
10.1.2.1 Company overview
10.1.2.2 Product benchmarking
10.1.3 TECAN TRADING AG
10.1.3.1 Company overview
10.1.3.2 Financial Performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 SCIGENOM LABS PVT. LTD
10.1.4.1 Company overview
10.1.4.2 Product benchmarking
10.1.4.3 Strategic initiatives
10.1.5 XCELRIS LABS LTD. (XCELRIS GENOMICS)
10.1.5.1 Company overview
10.1.5.2 Product benchmarking
10.1.6 EUROFINS SCIENTIFIC
10.1.6.1 Company overview
10.1.6.2 Financial Performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 4BASECARE
10.1.7.1 Company overview
10.1.7.2 Financial Performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 MEDGENOME
10.1.8.1 Company overview
10.1.8.2 Product benchmarking
10.1.8.3 Strategic initiatives
10.1.9 SAYRE THERAPEUTICS
10.1.9.1 Company overview
10.1.9.2 Product benchmarking
10.1.9.3 Strategic initiatives
10.1.10 REDCLIFFE LIFE SCIENCES PVT. LTD.
10.1.10.1 Company overview
10.1.10.2 Product benchmarking
10.1.11 PARTEK INCORPORATED
10.1.11.1 Company overview
10.1.11.2 Financial Performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 BIO-RAD LABORATORIES, INC.
10.1.12.1 Company overview
10.1.12.2 Financial Performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 MYRIAD GENETICS, INC.
10.1.13.1 Company overview
10.1.13.2 Financial Performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 HOLOGIC, INC. (GEN-PROBE INCORPORATED)
10.1.14.1 Company overview
10.1.14.2 Financial Performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives
10.1.15 PERKIN ELMER, INC.
10.1.15.1 Company overview
10.1.15.2 Horizon Discovery Group plc
10.1.15.2.1 Company overview
10.1.15.3 Financial Performance
10.1.15.4产品基准测试
10.1.15.5 Strategic initiatives
10.1.16 VELA DIAGNOSTICS
10.1.16.1 Company overview
10.1.16.2 Financial Performance
10.1.16.3 Product benchmarking
10.1.16.4 Strategic initiatives
10.1.17 PREMAS LIFE SCIENCES
10.1.17.1 Company overview
10.1.17.2 Financial Performance
10.1.17.3 Product benchmarking

List of Tables

Table 1 Top 5 cancer insurance plans in India
Table 2 Quantitative outcome of government initiatives for genomics in India (2015 - 2020)
Table 3 NGS DNA testing cost in India
Table 4 Illumina Workflows to Address COVID-19
表5基因Redcliffe覆盖生命科学的comprehensive hereditary cancer panel
Table 6 Library preparation kits used by MedGenome
Table 7 NGS platform users

List of Figures

Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 QFD modeling for market share assessment of NGS data analysis workflows
Fig. 9 Commodity flow analysis
Fig. 10 Market segmentation & scope
Fig. 11 India oncology NGS market snapshot, USD Million, 2020
Fig. 12 Generations of sequencing
Fig. 13 Different NGS technologies and types of analysis
Fig. 14 Common DNA sequencing methods
Fig. 15 Penetration and growth prospect mapping, by technology
Fig. 16 Medical vs. non-medical expenditure for cancer care in India
Fig. 17 Key priority areas of Human Genetics & Genome Analysis program of DBT
Fig. 18 Key initiatives of DBT India
Fig. 19 India oncology NGS market driver impact
Fig. 20 Estimated number of new cancer cases in India, both sexes, age: 0-85+ (Million cases)
Fig. 21 India oncology NGS market restraint impact
Fig. 22 India oncology NGS market opportunity impact
Fig. 23 SWOT analysis, by factor (Political & legal, economic, and technological)
Fig. 24 Porter’s Five Forces Analysis
Fig. 25 Key macroeconomic challenges associated with the pandemic
Fig. 26 Key elements to enhance the supply chain post COVID-19
Fig. 27 Role of NGS to combat COVID-19 outbreak
Fig. 28 Recent developments & impact analysis, by key market participants
Fig. 29 India oncology NGS market: Technology outlook and key takeaways
Fig. 30 India oncology NGS market: Technology movement analysis
Fig. 31 India oncology whole genome sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 32 India oncology whole exome sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 33 India oncology targeted & gene panel sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 34 India oncology NGS amplicon-based market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 35 India oncology NGS hybridization-based market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 36 India oncology NGS market: Application outlook and key takeaways
Fig. 37 India oncology NGS market: Application movement analysis
Fig. 38 India NGS-based oncology diagnostics and screening market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 39 India NGS-based oncology screening market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 40 India NGS-based sporadic cancer screening market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 41 India NGS-based inherited cancer screening market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 42 India NGS-based oncology CDx market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 43 India NGS-based other oncology diagnostics market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 44 India NGS-based oncology research studies market estimates and forecast, 2017 - 2028 (USD Million)
图45印度杂志ogy next-generation sequencing market: Product & service outlook and key takeaways
Fig. 46 India oncology next-generation sequencing market: Product & service movement analysis
Fig. 47 India oncology NGS platforms and related products market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 48 India oncology NGS panel market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 49 NGS consumables market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 50 India oncology NGS platforms market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 51 India oncology NGS services market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 52 India oncology NGS market: Workflow outlook and key takeaways
Fig. 53 India oncology NGS market: Workflow movement analysis
Fig. 54 India oncology NGS pre-sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 55 India oncology NGS library preparation kits market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 56 India oncology semi-automated library preparation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 57 India oncology automated library preparation market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 58 India oncology clonal amplification market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 59 India oncology NGS sequencing market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 60 India oncology NGS data analysis market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 61 India oncology NGS primary data analysis market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 62 India oncology NGS secondary data analysis market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 63 India oncology NGS tertiary data analysis market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 64 India oncology next-generation sequencing market: End-use outlook and key takeaways
Fig. 65 India oncology next-generation sequencing market: End-use movement analysis
Fig. 66 Academic research-based India oncology NGS market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 67 Clinical research-based India oncology NGS market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 68 Hospitals & clinics -based India oncology NGS market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 69 Pharma & biotech entities -based India oncology NGS market estimates and forecast, 2017 - 2028 (USD Million)
Fig. 70 Other users-based India oncology NGS market estimates and forecast, 2017 - 2028 (USD Million)